Date published: 2026-3-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR35 Activators

GPR35 activators are compounds that target and modulate the activity of the G-protein coupled receptor 35 (GPR35), a cell surface receptor implicated in a myriad of biological processes due to its influence on intracellular signaling pathways. This class of chemicals can bind to the GPR35 receptor, which is predominantly expressed in the gastrointestinal tract, immune cells, and the central nervous system. Activation of GPR35 can lead to various intracellular responses, primarily through the coupling of the receptor to G-proteins that can trigger downstream signaling cascades. Such cascades often involve the modulation of intracellular cyclic AMP (cAMP) levels, ion channel regulation, and the activation of kinases and other signaling molecules that are central to cellular responses. The diversity of GPR35 activators stems from the receptor's ability to be engaged by a wide range of ligands, including small molecules, peptides, and ions.The GPR35 receptor is known for its promiscuous binding profile, allowing it to be activated by a variety of structurally diverse compounds, including endogenous ligands like kynurenic acid, as well as synthetic molecules. GPR35 activators can behave as full agonists, partial agonists, or allosteric modulators of the receptor, which means that their interaction with GPR35 can induce different conformational changes in the receptor and consequently lead to varied levels of receptor activation. The activation of GPR35 can influence several signaling pathways, including those involving β-arrestins, which can mediate receptor desensitization, internalization, and the initiation of distinct signaling events independent of G-proteins. The multifaceted nature of GPR35 signaling implies that the activators of this receptor can have diverse effects on cellular functions, depending on the cell type, the signaling context, and the specific activator involved.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB)

107254-86-4sc-201542
sc-201542B
sc-201542A
10 mg
25 mg
50 mg
$109.00
$193.00
$317.00
7
(1)

5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) acts as a GPR35 modulator, exhibiting a unique ability to stabilize receptor conformation through hydrophobic interactions and hydrogen bonding. This compound influences intracellular calcium signaling pathways, promoting distinct cellular responses. Its structural features enable selective receptor engagement, while its dynamic solubility enhances bioavailability, allowing for effective modulation of GPR35 activity in various environments.

Niflumic acid

4394-00-7sc-204820
5 g
$32.00
3
(1)

Niflumic acid serves as a GPR35 modulator, characterized by its ability to engage in specific electrostatic interactions with receptor sites, influencing downstream signaling cascades. Its unique structural configuration allows for selective binding, which alters receptor dynamics and enhances signal transduction efficiency. Additionally, the compound's amphiphilic nature facilitates membrane permeability, promoting effective cellular uptake and interaction with lipid bilayers, thereby impacting GPR35-mediated pathways.

Rosmarinic Acid

20283-92-5sc-202796
sc-202796A
10 mg
50 mg
$58.00
$109.00
4
(1)

Rosmarinic acid acts as a GPR35 modulator, exhibiting a distinctive ability to form hydrogen bonds with key amino acid residues within the receptor. This interaction stabilizes the receptor's active conformation, leading to enhanced signaling pathways. Its polyphenolic structure contributes to its antioxidant properties, influencing cellular redox states. Furthermore, the compound's solubility in various solvents aids in its bioavailability, facilitating its engagement with GPR35 in diverse biological contexts.

D-Luciferin potassium salt

115144-35-9sc-278918
50 mg
$122.00
(1)

D-Luciferin potassium salt serves as a GPR35 ligand, characterized by its unique bioluminescent properties that arise from its interaction with the receptor. This compound engages in specific hydrophobic interactions, promoting receptor activation and downstream signaling cascades. Its structural flexibility allows for rapid conformational changes, enhancing reaction kinetics. Additionally, the salt form improves solubility, facilitating effective receptor engagement in various environments.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Zaprinast (M&B 22948) acts as a GPR35 modulator, distinguished by its ability to selectively bind to the receptor, influencing intracellular calcium signaling. Its unique molecular structure enables specific hydrogen bonding and hydrophobic interactions, which stabilize the receptor-ligand complex. The compound exhibits notable reaction kinetics, allowing for swift activation of downstream pathways. Furthermore, its lipophilic nature enhances membrane permeability, optimizing its interaction dynamics within cellular environments.

Pamoic acid disodium salt

6640-22-8sc-362777
25 g
$63.00
(0)

Pamoic acid disodium salt serves as a GPR35 modulator, characterized by its capacity to engage in unique electrostatic interactions with the receptor. This compound facilitates the activation of signaling cascades through distinct conformational changes in the receptor structure. Its dual ionic nature promotes solubility in aqueous environments, enhancing its bioavailability. Additionally, the compound's ability to form stable complexes with GPR35 underscores its potential for influencing various intracellular processes.

Pamoic acid

130-85-8sc-212523
100 g
$92.00
(0)

Pamoic acid serves as a GPR35 modulator, characterized by its capacity to engage in ionic and hydrogen bonding interactions with the receptor. This compound promotes receptor activation through a unique mechanism that alters the spatial arrangement of key amino acids, facilitating signal transduction. Its amphipathic nature enhances its interaction with lipid bilayers, optimizing its localization and efficacy in cellular environments. The compound's distinct binding dynamics further shape its influence on receptor-mediated pathways.

Compound 10

123021-85-2sc-364688
sc-364688A
5 mg
25 mg
$111.00
$432.00
(0)

Compound 10 acts as a GPR35 modulator, exhibiting a unique ability to stabilize receptor dimers through hydrophobic interactions. This compound initiates specific signaling pathways by inducing allosteric changes in the receptor's conformation. Its lipophilic characteristics enhance membrane permeability, allowing for efficient receptor engagement. Furthermore, Compound 10's selective binding affinity contributes to its distinct kinetic profile, influencing downstream cellular responses.